You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
TOPIC 372: DEVELOPMENT AND VALIDATION OF CANINE SCFVS FOR PRE-CLINICAL DEVELOPMENT OF TARGETED THERAPEUTICS
SBC: Vetigenics LLC Topic: NCIThe goal of this SBIR is to provide proof of concept of Vetigenicscanine derived scFv phage display platform for rapidcost effective production of highly versatilecanine derived scFvsscFvs against CDCDand CTLAthree high valueimmunological molecules being targeted by antibody based strategies in human cancer immunotherapywill be isolatedSelected scFvs will be sequenced and binding affinities determ ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
History Maker VR
SBC: Schell Games LLC Topic: 91990019R0012History Maker VR is a playful virtual reality (VR) content-creation tool that allows students to embody historical characters in immersive settings, record performances featuring those characters, and share their performance files to demonstrate material mastery. History Maker VR is designed to scaffold creative storytelling, and to encourage embodied learning and for students to take pride in con ...
SBIR Phase II 2019 Department of EducationInstitute of Education Sciences -
Non-Thermal Plasma Assisted Inactivation of Antibiotic Resistant Bacteria in Wastewater
SBC: AA PLASMA LLC Topic: 18NCER1AFactors such as an increase in global antibiotic availability, inadequate treatment of wastewater from pharmaceutical manufacturing facilities, uncontrolled or over-the-counter antibiotic sales, and high antibiotic use in livestock feed have led to the rapidly-developing threat of antibiotic resistant bacteria (ARB). This rise in infection incidence from pathogens resistant to our main medical def ...
SBIR Phase I 2019 Environmental Protection Agency -
Plasma-Enhancement of Absorbers for Improved Removal of PFOS and PFOA from Water
SBC: AA PLASMA LLC Topic: 18NCERP2New regulations and advisory levels for perfluoroalkyl substances have resulted in increased drinking water treatment costs or abandonment of drinking water sources. Treatment technologies are needed that can achieve low parts-per-trillion levels. Presently, there are insufficient treatment technologies that can destructively remove perfluorooctanoic acid (PFOA) and/or perfluorooctane sulfonic aci ...
SBIR Phase II 2019 Environmental Protection Agency -
Antibody Fragments to Improve HIV gp120 Protein Production
SBC: ABZYME THERAPEUTICS LLC Topic: NIAIDCamelid single domain antibody fragmentsVHHpossess a number of distinctive features including a small sizean elevated stabilityand an ability to recognize epitopes non accessible for conventional antibodiesBesides common research and immunotherapy applicationscamelid VHHs are also used as co crystallization chaperonesprotein aggregation controllers and enzyme activity tunersIn this proposalwe wish ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
TOPIC 386: PROOF OF CONCEPT FOR A TOPICAL MEK INHIBITOR AS A CHEMOPREVENTIVE AGENT FOR SQUAMOUS CELL CARCINOMA IN HIGH RISK ORGAN TRANSPLANT PATIENTS
SBC: NFlection Therapeutics, Inc. Topic: NCISolid organ transplantation can be life savingHoweverimmunosuppression necessary to prevent rejection increases the incidence of cutaneous squamous cell carcinomacSCCfoldCurrent treatments for solid organ transplant recipientsSOTRsare largely surgicalwhich can be disfiguring and impact quality of lifeThere is a huge need for a safe and effective chemoprevention agent for cSCC in SOTRsThe RAF MEK E ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A Novel Synthetic Vascular Graft Capable of Minimally Invasive Controlled Expansion for Vascular Reconstruction Model
SBC: PECA LABS INC Topic: NHLBIPROJECT SUMMARY In pediatric cardiovascular surgery, no commercially available vascular conduit is capable of growing with the patient following implantation. This inability to grow with the patient is particularly relevant for newborns and young children because additional surgeries are required to replace the implanted conduit. In order to address this issue, PECA Labs has developed a novel card ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Mechanical generation of peri-valvular oscillatory flow to prevent deep venous thrombosis.
SBC: OSCIFLEX LLC Topic: NHLBIProject SummaryDeep venous thrombosisDVTand secondary pulmonary embolismPEaffectof the population and cause approximatelydeaths annually in the USImmobility and lack of muscular activity is the primary risk factor for DVTan effect attributed to reduced venous flowAutopsy studies have identified the venous valve sinus in the leg as the site of origin for DVTbut a molecular and cellular mechanism fo ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Preclinical Evaluation of an SCN8A-directed Splice Modulating Oligonucleotide to Treat Dravet Syndrome
SBC: LifeSplice Pharma Topic: 106Project Summary Abstract Dravet Spectrum disorders resulting from SCN A loss of functionLOFmutations include febrile seizuresgeneralized epilepsy with febrile seizure plusGEFSand Dravet SyndromeDSin order of severityDS symptoms begin in infancy and lead to progressive developmental and behavioral impairments along with characteristic recurrent and varied seizuresIn many patientsseizures are resist ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
Facilitating Blinded Data Acquisition and Analysis to Increase Rigor in Biomedical Research
SBC: SciBlinder LLC Topic: 400Project Summary AbstractRecentlythe NIH and various journals issued guidelines intended to increase rigor in biomedical scienceThe removal of bias through blinding was identified as a central means for improving rigorThe effects of unintentional bias can be easy to overlookand blinding procedures are often time consuming and tediousDue to this perceived lack of need and high effort requirementblin ...
SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health